News

Investigation of Soleno Therapeutics Over Securities Concerns

Investigation of Soleno Therapeutics Over Securities Concerns

Pomerantz Law Firm's Investigation into Soleno Therapeutics

Pomerantz LLP has launched an investigation on behalf of investors of Soleno Therapeutics, Inc. (NASDAQ: SLNO). The firm aims to uncover potential legal issues that may affect shareholders.

Details of the Investigation

The investigation is focused on whether Soleno and certain officers or directors have engaged in securities fraud or other unlawful practices that may have harmed investors.

Concerns Following a Recent Report

On a significant date, a report was released by Scorpion Capital that raised alarms about Soleno's main product, Vykat XR. The report labeled the product as overpriced and potentially unsafe for children, sparking concerns among investors and regulators.

Impact on Stock Performance

The release of the Scorpion report had a marked effect on Soleno's stock. Following this revelation, the company experienced a notable decrease in share price, dropping by 7.41%, which translated to a loss of $5.73 per share, closing at $71.63.

About Pomerantz LLP

Pomerantz LLP is recognized as a leading firm specializing in corporate, securities, and antitrust class litigation. Established by the late Abraham L. Pomerantz, the firm has built a strong reputation over more than eight decades, continuously advocating for the rights of victims against securities fraud and corporate misconduct. With offices in major cities around the world, Pomerantz has achieved several multimillion-dollar recoveries for class members, reinforcing its commitment to corporate justice.

Contact Information for Affected Investors

Investors who feel impacted by the recent developments about Soleno Therapeutics are encouraged to reach out to Danielle Peyton at Pomerantz LLP. They can provide needed support and advice regarding potential claims.

Frequently Asked Questions

What is Soleno Therapeutics known for?

Soleno Therapeutics specializes in developing innovative treatments for various medical conditions, notably their product Vykat XR.

Why is Pomerantz investigating Soleno?

Pomerantz is investigating allegations of securities fraud and potentially unlawful business practices that could impact shareholders.

What was the result of the Scorpion report?

The Scorpion Capital report significantly affected Soleno's stock price, leading to a sharp decline after its release.

How has Pomerantz helped investors in the past?

Pomerantz has a long history of winning substantial settlements for victims of securities fraud and corporate malfeasance.

If I am a Soleno investor, how can I get assistance?

Investors are urged to contact Pomerantz LLP for potential assistance regarding claims related to Soleno Therapeutics.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Windward Bio Surges 68% in Nasdaq Debut

Updated Category News Views 173

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Continue Reading
Motphys Unleashes MotrixSim 1.0, Aiming at Simulation Dominance

Updated Category News Views 184

Motphys Breaks into the Global Simulation Scene The tech world just got slammed with what might be a seismic shift: Motphys, a bold outfit hailing from China, has dropped its brand-new, homegrown simulation engine, MotrixSim 1.0. It's causing quite the stir, unveiling at the Conference on Robot Learning 2026 (CoRL) and throwing down the gauntlet to Western titans like...

Continue Reading
HiTHIUM Joins Cambridge to Boost Global Energy Storage

Updated Category News Views 303

HiTHIUM and Cambridge's New Energy Venture There's a big splash coming out of Xiamen, folks. HiTHIUM, a heavyweight in the energy storage sector, has decided to team up with the University of Cambridge. They inked a deal aiming to bridge the academic ivory tower with industrial grit, focusing on long-duration energy storage. It was all sealed during the Global Energy...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 0

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 95

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
BETR's Slide: Investors Face Big Losses, Leadership Shift

Updated Category News Views 84

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

Continue Reading
LaserAway Expands to 244 Clinics Over 20 Years

Updated Category News Views 168

A Milestone in Aesthetic Dermatology Twenty years, folks. That's a long haul for most businesses, let alone one in the fickle field of aesthetic dermatology. LaserAway, the juggernaut in this arena, has just opened its 244th clinic at 6300 Kingery Hwy in Willowbrook, IL. Nothing to be sneezed at. Imagine running a business, let alone one that's been amping up aesthetic...

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 106

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 281

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
Samuel Oschin Center Opens, Promising Wonder

Updated Category News Views 192

A Grand New Space for Space Well, here's a sight for sore eyes—California Science Center's Samuel Oschin Air and Space Center just swung its doors open wide, and boy, it's a beast of a place. Housing a spectacle like the Space Shuttle Endeavour in a vertical launch position, it's as if they've reached up and snagged a piece of the sky itself for their exhibits. They're...

Continue Reading
s-holiday-gift-edit-timeless-watches-shine-542604-/" title="PASCAL's Holiday Gift Edit: Timeless Watches Shine - Continue Reading" aria-label="Continue reading: PASCAL's Holiday Gift Edit: Timeless Watches Shine"> Continue Reading